Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
European Journal of Cancer & Clinical Oncology
|
June 1, 1988
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma
Z Pastran, T le Chevalier, P Baldeyrou, et al.
Presse Medicale (Paris, France : 1983)
|
September 21, 1991
[Metastases from cancers of unknown primary site. Data from 302 autopsies]
A Le Cesne, T Le Chevalier, P Caille, et al.
Annales De Medecine Interne
|
October 1, 1978
[Rosai and Dorfman's syndrome]
J L Amiel, R Gérard-Marchant, B Caillou, et al.
Journal D'Urologie
|
January 1, 1980
[Cis-diamminated-dichloroplatinum (CDDP) in the chemotherapy of testicular dysembryomas and choriocarcinomas (author's transl)]
J L Amiel, J P Droz, T Tursz, et al.
Bulletin Du Cancer
|
January 1, 1985
[Chemotherapy by ambulatory continuous infusion using a portable pump: a feasibility trial]
M Benahmed, P Carde, A Laplanche, et al.
La Nouvelle Presse Medicale
|
December 18, 1976
[Current treatment of testicular cancers]
J L Amiel, J Cukier, J Vacant, et al.
Annales De Pathologie
|
January 1, 1985
[Alveolar soft part sarcomas. Apropos of 6 cases and review of the literature]
K Ben Romdhane, M J Lacombe, A Boddaert, et al.
Cancer Treatment Reports
|
May 1, 1985
Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung
T Le Chevalier, R Arriagada, P Baldeyrou, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1980
Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137)
C Paoletti, J B Le Pecq, N Dat-Xuong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1990
Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study
G Blackledge, A van Oosterom, H Mouridsen, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
European Journal of Cancer & Clinical Oncology
|
June 1, 1988
Phase II study of high dose ifosfamide plus mesna in inoperable non small cell lung carcinoma
Z Pastran, T le Chevalier, P Baldeyrou, et al.
Presse Medicale (Paris, France : 1983)
|
September 21, 1991
[Metastases from cancers of unknown primary site. Data from 302 autopsies]
A Le Cesne, T Le Chevalier, P Caille, et al.
Annales De Medecine Interne
|
October 1, 1978
[Rosai and Dorfman's syndrome]
J L Amiel, R Gérard-Marchant, B Caillou, et al.
Journal D'Urologie
|
January 1, 1980
[Cis-diamminated-dichloroplatinum (CDDP) in the chemotherapy of testicular dysembryomas and choriocarcinomas (author's transl)]
J L Amiel, J P Droz, T Tursz, et al.
Bulletin Du Cancer
|
January 1, 1985
[Chemotherapy by ambulatory continuous infusion using a portable pump: a feasibility trial]
M Benahmed, P Carde, A Laplanche, et al.
La Nouvelle Presse Medicale
|
December 18, 1976
[Current treatment of testicular cancers]
J L Amiel, J Cukier, J Vacant, et al.
Annales De Pathologie
|
January 1, 1985
[Alveolar soft part sarcomas. Apropos of 6 cases and review of the literature]
K Ben Romdhane, M J Lacombe, A Boddaert, et al.
Cancer Treatment Reports
|
May 1, 1985
Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung
T Le Chevalier, R Arriagada, P Baldeyrou, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1980
Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137)
C Paoletti, J B Le Pecq, N Dat-Xuong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1990
Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study
G Blackledge, A van Oosterom, H Mouridsen, et al.
Page
of 6